Observational studyArquivos de gastroenterologia2026
EVALUATION OF CLINICAL ASPECTS OF PATIENTS UNDERGOING SACRAL NEUROMODULATION FOR FECAL INCONTINENCE: A RETROSPECTIVE MULTICENTER STUDY.
Observational study in Arquivos de gastroenterologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFecal incontinence affects approximately 5%-10% of non-institutionalized individuals and is associated with socioeconomic burden. A meaningful proportion of patients fail conservative management and may require interventional therapies. Sacral neuromodulation has emerged as a less invasive option with favorable outcomes in clinical practice.
objectiveTo describe clinical and demographic characteristics and to assess fecal incontinence severity and fecal urgency before and after sacral neuromodulation implantation in Brazilian centers.
methodsObservational study including patients who underwent sacral neuromodulation implantation for fecal incontinence refractory to conservative treatment. Clinical-demographic variables, previous treatments, surgical implantation aspects, and the Wexner fecal incontinence score before and after the procedure were collected. All patients underwent anorectal manometry. Additional examinations were performed according to clinical indication. The study was approved by the local Ethics Committee.
resultsA total of 87 patients were included; 72 (82.8%) were female, with a mean age of 61.22±16.32 years. Most patients were economically active (56.3%), had completed secondary education (44.8%), and were married (60.9%). The most frequent etiology was neurogenic (42; 48.3%), with a mean disease duration of 73.9±61.33 months. Among women, 17 were nulliparous. Previous surgeries included perineal procedures in 22 (25.3%), colorectal surgery in 16 (18.4%), and pelvic surgery in 12 (13.8%). Only 12 (13.8%) patients had undergone prior surgery specifically for fecal incontinence. Additional tests included endoanal ultrasound (52.9%), colonoscopy (26.4%), electromyography (31%), and pelvic magnetic resonance imaging (2.3%). The median Wexner score decreased after implantation (16; interquartile range: 12-17 vs 2; interquartile range: 0-4), and fecal urgency frequency decreased (51.7% vs 26.4%).
conclusionIn Brazilian centers, sacral neuromodulation was associated with clinically meaningful reductions in fecal incontinence severity and fecal urgency among patients refractory to conservative treatment, with a safety profile consistent with the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.